Concepedia

Publication | Open Access

Best infection control practices for intradermal, subcutaneous, and intramuscular needle injections.

244

Citations

51

References

2003

Year

TLDR

Best infection control practices for intradermal, subcutaneous, and intramuscular injections involve using sterile equipment, preventing contamination, avoiding needle‑stick injuries, and ensuring no access to used needles, providing a global reference for safe injection use. The study aims to develop evidence‑based guidelines to make injections safer and to have WHO revise them five years after initial development. A development group reviewed WHO’s safe injection definition, conducted literature reviews for each critical step, formulated best practices, and submitted the draft for peer review, with the process finalized in 2005. Eliminating unnecessary injections is identified as the highest priority for preventing injection‑associated infections.

Abstract

To draw up evidence-based guidelines to make injections safer.A development group summarized evidence-based best practices for preventing injection-associated infections in resource-limited settings. The development process included a breakdown of the WHO reference definition of a safe injection into a list of potentially critical steps, a review of the literature for each of these steps, the formulation of best practices, and the submission of the draft document to peer review.Eliminating unnecessary injections is the highest priority in preventing injection-associated infections. However, when intradermal, subcutaneous, or intramuscular injections are medically indicated, best infection control practices include the use of sterile injection equipment, the prevention of contamination of injection equipment and medication, the prevention of needle-stick injuries to the provider, and the prevention of access to used needles.The availability of best infection control practices for intradermal, subcutaneous, and intramuscular injections will provide a reference for global efforts to achieve the goal of safe and appropriate use of injections. WHO will revise the best practices five years after initial development, i.e. in 2005.

References

YearCitations

Page 1